exp_id,keyword
FR-FCM-ZZZ3,Innate Immune Response
FR-FCM-ZZZ3,Toll-like receptors
FR-FCM-ZZZ3,Activation markers
FR-FCM-ZZZ3,B cells
FR-FCM-ZZZ3,MIFlowCyt
FR-FCM-ZZZ4,FCS
FR-FCM-ZZZ4,test
FR-FCM-ZZZ4,compliance
FR-FCM-ZZZA,Human early preterm cord blood
FR-FCM-ZZZA,CD34
FR-FCM-ZZZA,hematopoietic stem cells
FR-FCM-ZZZF,CLL
FR-FCM-ZZZF,hairy cell leukemia
FR-FCM-ZZZK,HIV
FR-FCM-ZZZK,Bioinformatics
FR-FCM-ZZZK,AIDS Free Survival
FR-FCM-ZZZU,Classification
FR-FCM-ZZZU,Bioinformatics
FR-FCM-ZZZU,HIV exposed but uninfected
FR-FCM-ZZZU,HIV unexposed
FR-FCM-ZZZV,FlowCAP
FR-FCM-ZZZV,Bioinformatics
FR-FCM-ZZZV,Intracellular Cytokine Staining
FR-FCM-ZZZV,HVTN
FR-FCM-ZZZV,ICS
FR-FCM-ZZYZ,Bioinformatics
FR-FCM-ZZYZ,flow cytometry
FR-FCM-ZZYZ,automated gating
FR-FCM-ZZYY,Lymphoma
FR-FCM-ZZYY,Bioinformatics
FR-FCM-ZZYY,diffuse large B-cell lymphoma
FR-FCM-ZZYY,automated gating
FR-FCM-ZZY2,Bioinformatics
FR-FCM-ZZY2,GvHD
FR-FCM-ZZY2,automatic gating
FR-FCM-ZZY3,West Nile Virus
FR-FCM-ZZY3,Tansplantation
FR-FCM-ZZY3,cytokines
FR-FCM-ZZY6,hematopoietic stem cells
FR-FCM-ZZY6,Transplantation
FR-FCM-ZZY6,lymphoid
FR-FCM-ZZY7,flow cytometry
FR-FCM-ZZY7,High Throughput
FR-FCM-ZZY7,Doublet
FR-FCM-ZZY7,Mean Fluorescence Intensity (MFI)
FR-FCM-ZZY7,linear and quadratic regressions
FR-FCM-ZZY7,Q (detector efficiency)
FR-FCM-ZZY7,B (background light level)
FR-FCM-ZZY7,Instrument Sensitivity
FR-FCM-ZZY7,K-means
FR-FCM-ZZY7,Molecules of Equivalent Soluble Fluorochrome (MESF)
FR-FCM-ZZY7,BD CS&T beads
FR-FCM-ZZY7,Kmeans Automatic Clustering
FR-FCM-ZZY9,bleaching response; zooxanthellae; chlorophyll; flow cytometry; microscopy
FR-FCM-ZZYA,Classification
FR-FCM-ZZYA,Bioinformatics
FR-FCM-ZZYA,flow cytometry
FR-FCM-ZZYA,Acute Myeloid Leukemia
FR-FCM-ZZYE,AmCyan100
FR-FCM-ZZYE,Stain Index
FR-FCM-ZZYE,Spillover
FR-FCM-ZZYF,Neutrophil
FR-FCM-ZZYF,autoimmune
FR-FCM-ZZYF,isolation
FR-FCM-ZZYF,spleen
FR-FCM-ZZYK,flow cytometry
FR-FCM-ZZYK,Cryoglobulins
FR-FCM-ZZYK,detection
FR-FCM-ZZYL,ICS; standardization; reproducibility; positivity threshold; F-score; automated analysis
FR-FCM-ZZYQ,5-ethynyl-2’-deoxyuridine; T lymphocyte] [proliferation; surface antibodies
FR-FCM-ZZYR,Cancer
FR-FCM-ZZYR,metastasis
FR-FCM-ZZYR,circulating tumor cells (CTCs)
FR-FCM-ZZYR,CD44
FR-FCM-ZZYR,M-30
FR-FCM-ZZYR,CellSearch® system
FR-FCM-ZZYR,user-defined marker
FR-FCM-ZZYR,CTC characterization
FR-FCM-ZZ2Z,Immunophenotyping
FR-FCM-ZZ2Y,Immunophenotyping
FR-FCM-ZZ23,Immunophenotyping
FR-FCM-ZZ24,Immunophenotyping
FR-FCM-ZZ28,Immunophenotyping
FR-FCM-ZZ29,Autophagy LC3B LTG Annexinn V
FR-FCM-ZZ2B,DFI
FR-FCM-ZZ2B,Sperm
FR-FCM-ZZ2B,IUI
FR-FCM-ZZ2L,Intracellular Cytokine Staining
FR-FCM-ZZ2L,T cell
FR-FCM-ZZ2M,multicolor flow cytometry
FR-FCM-ZZ2M,chemokine receptor
FR-FCM-ZZ2M,antibody staining
FR-FCM-ZZ2M,monocyte
FR-FCM-ZZ2P,PBMC
FR-FCM-ZZ2P,signaling
FR-FCM-ZZ2T,Innate Immune Response
FR-FCM-ZZ2T,Intracellular cytokines; CD8 T cells
FR-FCM-ZZ2T,CD4 T cells; HIV; SIV; vaccines
FR-FCM-ZZ2U,CD34
FR-FCM-ZZ2U,CD14
FR-FCM-ZZ2U,BREAST CANCER STEM CELL
FR-FCM-ZZ2V,[Immune Response] [Intracellular cytokines]; [CD8 T cells] [CD4 T cells]; [HIV]; [SIV]; [vaccines] [human]
FR-FCM-ZZ3Z,Innate Immune Response
FR-FCM-ZZ3Z,CD4 T cells; HIV; SIV; vaccines
FR-FCM-ZZ3Z,Intracellular cytokines; CD8 T cells; optimization
FR-FCM-ZZ3Y,Innate Immune Response
FR-FCM-ZZ3Y,Intracellular cytokines; CD8 T cells
FR-FCM-ZZ3Y,CD4 T cells; HIV; SIV; vaccines
FR-FCM-ZZ32,HIV
FR-FCM-ZZ32,APOPTOSIS
FR-FCM-ZZ32,CASPASE
FR-FCM-ZZ33,interleukin-1 receptor; peripheral blood mononuclear cells; quantitative analysis.
FR-FCM-ZZ36,chemokine receptors
FR-FCM-ZZ36,T cell Phenotyping
FR-FCM-ZZ36,T cell memory subsets
FR-FCM-ZZ38,Gene expression
FR-FCM-ZZ3L,nanoparticle
FR-FCM-ZZ3L,trigger
FR-FCM-ZZ3L,fluorescence
FR-FCM-ZZ3L,light scatter
FR-FCM-ZZ3M,B cells
FR-FCM-ZZ3M,T cell
FR-FCM-ZZ3M,PBMC
FR-FCM-ZZ3M,EMBO
FR-FCM-ZZ3M,CD5
FR-FCM-ZZ3M,CD20
FR-FCM-ZZ3N,B cells
FR-FCM-ZZ3N,trigger
FR-FCM-ZZ3N,BCR
FR-FCM-ZZ3N,IgM
FR-FCM-ZZ3X,Purity Sort
FR-FCM-ZZ3X,T cell
FR-FCM-ZZ3X,Ficoll
FR-FCM-ZZ3X,CD4
FR-FCM-ZZ4B,flow cytometry
FR-FCM-ZZ4B,lymphocyte subsets
FR-FCM-ZZ4B,CD7 antigen
FR-FCM-ZZ4B,CD33 antigen
FR-FCM-ZZ4B,NK cells
FR-FCM-ZZ4B,monocytes
FR-FCM-ZZ4B,basophils
FR-FCM-ZZ4E,flow cytometry; data analysis; statistical analysis; normalization
FR-FCM-ZZ4G,calcium influx
FR-FCM-ZZ4G,data analysis
FR-FCM-ZZ4G,kinetic flow cytometry
FR-FCM-ZZ4G,potassium channel
FR-FCM-ZZ4G,rheumatoid arthritis
FR-FCM-ZZ4G,T lymphocyte
FR-FCM-ZZ4W,Ly49G2
FR-FCM-ZZ4W,Ly49I/U
FR-FCM-ZZ4W,H-2k
FR-FCM-ZZ4W,MHC
FR-FCM-ZZ4W,NKC
FR-FCM-ZZ4W,NKp46
FR-FCM-ZZ4W,NCR
FR-FCM-ZZ4W,14B11
FR-FCM-ZZ4W,4D11
FR-FCM-ZZ4J,Ly49G2
FR-FCM-ZZ4J,Ly49I/U
FR-FCM-ZZ4J,H-2k
FR-FCM-ZZ4J,MHC
FR-FCM-ZZ4J,NKC
FR-FCM-ZZ4J,NKp46
FR-FCM-ZZ4J,NCR
FR-FCM-ZZ4J,14B11
FR-FCM-ZZ4J,4D11
FR-FCM-ZZ4J,MCMV
FR-FCM-ZZ4K,Ly49G2
FR-FCM-ZZ4K,Ly49I/U
FR-FCM-ZZ4K,H-2k
FR-FCM-ZZ4K,MHC
FR-FCM-ZZ4K,NKC
FR-FCM-ZZ4K,NKp46
FR-FCM-ZZ4K,NCR
FR-FCM-ZZ4K,14B11
FR-FCM-ZZ4K,4D11
FR-FCM-ZZ4L,Ly49G2
FR-FCM-ZZ4L,Ly49I/U
FR-FCM-ZZ4L,H-2k
FR-FCM-ZZ4L,MHC
FR-FCM-ZZ4L,NKC
FR-FCM-ZZ4L,NKp46
FR-FCM-ZZ4L,NCR
FR-FCM-ZZ4L,14B11
FR-FCM-ZZ4L,4D11
FR-FCM-ZZ4L,MCMV
FR-FCM-ZZ4N,Ly49G2
FR-FCM-ZZ4N,Ly49I/U
FR-FCM-ZZ4N,H-2k
FR-FCM-ZZ4N,MHC
FR-FCM-ZZ4N,NKC
FR-FCM-ZZ4N,NKp46
FR-FCM-ZZ4N,NCR
FR-FCM-ZZ4N,14B11
FR-FCM-ZZ4N,4D11
FR-FCM-ZZ4X,Ly49G2
FR-FCM-ZZ4X,Ly49I/U
FR-FCM-ZZ4X,H-2k
FR-FCM-ZZ4X,MHC
FR-FCM-ZZ4X,NKC
FR-FCM-ZZ4X,NKp46
FR-FCM-ZZ4X,NCR
FR-FCM-ZZ4X,14B11
FR-FCM-ZZ4X,4D11
FR-FCM-ZZ4X,MCMV
FR-FCM-ZZ4P,Flow cytometer sensitivity
FR-FCM-ZZ4Q,clonogenic assay
FR-FCM-ZZ4Q,clonogenic capacity
FR-FCM-ZZ4Q,plating efficiency
FR-FCM-ZZ4Q,cancer stem cells
FR-FCM-ZZ4Q,extreme limiting dilution analysis
FR-FCM-ZZ4Q,single cell sorting
FR-FCM-ZZ4V,NK cells
FR-FCM-ZZ4V,Ly49G2
FR-FCM-ZZ4V,Ly49I/U
FR-FCM-ZZ4V,H-2k
FR-FCM-ZZ4V,MHC
FR-FCM-ZZ4V,NKp46
FR-FCM-ZZ4V,NCR
FR-FCM-ZZ4V,14B11
FR-FCM-ZZ4V,4D11
FR-FCM-ZZ5Z,Ly49G2
FR-FCM-ZZ5Z,Ly49I/U
FR-FCM-ZZ5Z,H-2k
FR-FCM-ZZ5Z,MHC
FR-FCM-ZZ5Z,NKC
FR-FCM-ZZ5Z,NKp46
FR-FCM-ZZ5Z,NCR
FR-FCM-ZZ5Z,14B11
FR-FCM-ZZ5Z,4D11
FR-FCM-ZZ5Z,MCMV
FR-FCM-ZZ5Y,Ly49G2
FR-FCM-ZZ5Y,Ly49I/U
FR-FCM-ZZ5Y,H-2k
FR-FCM-ZZ5Y,MHC
FR-FCM-ZZ5Y,NKC
FR-FCM-ZZ5Y,NKp46
FR-FCM-ZZ5Y,NCR
FR-FCM-ZZ5Y,14B11
FR-FCM-ZZ5Y,4D11
FR-FCM-ZZ52,Ly49G2
FR-FCM-ZZ52,H-2k
FR-FCM-ZZ52,MHC
FR-FCM-ZZ52,NKC
FR-FCM-ZZ52,NKp46
FR-FCM-ZZ52,NCR
FR-FCM-ZZ52,14B11
FR-FCM-ZZ52,4D11
FR-FCM-ZZ52,MCMV
FR-FCM-ZZ53,Ly49G2
FR-FCM-ZZ53,Ly49I/U
FR-FCM-ZZ53,H-2k
FR-FCM-ZZ53,MHC
FR-FCM-ZZ53,NKC
FR-FCM-ZZ53,NKp46
FR-FCM-ZZ53,NCR
FR-FCM-ZZ53,14B11
FR-FCM-ZZ53,4D11
FR-FCM-ZZ54,Ly49G2
FR-FCM-ZZ54,Ly49I/U
FR-FCM-ZZ54,H-2k
FR-FCM-ZZ54,MHC
FR-FCM-ZZ54,NKC
FR-FCM-ZZ54,NKp46
FR-FCM-ZZ54,NCR
FR-FCM-ZZ54,14B11
FR-FCM-ZZ54,4D11
FR-FCM-ZZ54,MCMV
FR-FCM-ZZ55,Idiosyncratic drug-induced hepatotoxicity
FR-FCM-ZZ55,hepatic transporters
FR-FCM-ZZ55,MDR1
FR-FCM-ZZ55,MRP2
FR-FCM-ZZ55,microvolume cytometry
FR-FCM-ZZ5B,Ly49G2
FR-FCM-ZZ5B,Ly49I/U
FR-FCM-ZZ5B,H-2k
FR-FCM-ZZ5B,MHC
FR-FCM-ZZ5B,NKC
FR-FCM-ZZ5B,NKp46
FR-FCM-ZZ5B,NCR
FR-FCM-ZZ5B,14B11
FR-FCM-ZZ5B,4D11
FR-FCM-ZZ5C,Ly49G2
FR-FCM-ZZ5C,Ly49I/U
FR-FCM-ZZ5C,H-2k
FR-FCM-ZZ5C,MHC
FR-FCM-ZZ5C,NKC
FR-FCM-ZZ5C,NKp46
FR-FCM-ZZ5C,NCR
FR-FCM-ZZ5C,14B11
FR-FCM-ZZ5C,4D11
FR-FCM-ZZ5D,Ly49G2
FR-FCM-ZZ5D,Ly49I/U
FR-FCM-ZZ5D,H-2k
FR-FCM-ZZ5D,MHC
FR-FCM-ZZ5D,NKC
FR-FCM-ZZ5D,NKp46
FR-FCM-ZZ5D,NCR
FR-FCM-ZZ5D,14B11
FR-FCM-ZZ5D,4D11
FR-FCM-ZZ5D,MCMV
FR-FCM-ZZ5E,Ly49G2
FR-FCM-ZZ5E,Ly49I/U
FR-FCM-ZZ5E,H-2k
FR-FCM-ZZ5E,MHC
FR-FCM-ZZ5E,NKC
FR-FCM-ZZ5E,NKp46
FR-FCM-ZZ5E,NCR
FR-FCM-ZZ5E,14B11
FR-FCM-ZZ5E,4D11
FR-FCM-ZZ5F,Ly49G2
FR-FCM-ZZ5F,Ly49I/U
FR-FCM-ZZ5F,H-2k
FR-FCM-ZZ5F,MHC
FR-FCM-ZZ5F,NKC
FR-FCM-ZZ5F,NKp46
FR-FCM-ZZ5F,NCR
FR-FCM-ZZ5F,14B11
FR-FCM-ZZ5F,4D11
FR-FCM-ZZ5F,MCMV
FR-FCM-ZZ5H,Ly49G2
FR-FCM-ZZ5H,Ly49I/U
FR-FCM-ZZ5H,H-2k
FR-FCM-ZZ5H,MHC
FR-FCM-ZZ5H,NKC
FR-FCM-ZZ5H,NKp46
FR-FCM-ZZ5H,NCR
FR-FCM-ZZ5H,14B11
FR-FCM-ZZ5H,4D11
FR-FCM-ZZ5W,Ly49G2
FR-FCM-ZZ5W,Ly49I/U
FR-FCM-ZZ5W,H-2k
FR-FCM-ZZ5W,MHC
FR-FCM-ZZ5W,NKC
FR-FCM-ZZ5W,NKp46
FR-FCM-ZZ5W,NCR
FR-FCM-ZZ5W,14B11
FR-FCM-ZZ5W,4D11
FR-FCM-ZZ5J,Ly49G2
FR-FCM-ZZ5J,Ly49I/U
FR-FCM-ZZ5J,H-2k
FR-FCM-ZZ5J,MHC
FR-FCM-ZZ5J,NKC
FR-FCM-ZZ5J,NKp46
FR-FCM-ZZ5J,NCR
FR-FCM-ZZ5J,14B11
FR-FCM-ZZ5J,4D11
FR-FCM-ZZ5J,MCMV
FR-FCM-ZZ5K,Ly49G2
FR-FCM-ZZ5K,Ly49I/U
FR-FCM-ZZ5K,H-2k
FR-FCM-ZZ5K,MHC
FR-FCM-ZZ5K,NKC
FR-FCM-ZZ5K,NKp46
FR-FCM-ZZ5K,NCR
FR-FCM-ZZ5K,14B11
FR-FCM-ZZ5K,4D11
FR-FCM-ZZ5L,Ly49G2
FR-FCM-ZZ5L,Ly49I/U
FR-FCM-ZZ5L,H-2k
FR-FCM-ZZ5L,MHC
FR-FCM-ZZ5L,NKC
FR-FCM-ZZ5L,NKp46
FR-FCM-ZZ5L,NCR
FR-FCM-ZZ5L,14B11
FR-FCM-ZZ5L,4D11
FR-FCM-ZZ5L,MCMV
FR-FCM-ZZ5M,Ly49G2
FR-FCM-ZZ5M,Ly49I/U
FR-FCM-ZZ5M,H-2k
FR-FCM-ZZ5M,MHC
FR-FCM-ZZ5M,NKC
FR-FCM-ZZ5M,NKp46
FR-FCM-ZZ5M,NCR
FR-FCM-ZZ5M,14B11
FR-FCM-ZZ5M,4D11
FR-FCM-ZZ5N,Ly49G2
FR-FCM-ZZ5N,Ly49I/U
FR-FCM-ZZ5N,H-2k
FR-FCM-ZZ5N,MHC
FR-FCM-ZZ5N,NKC
FR-FCM-ZZ5N,NKp46
FR-FCM-ZZ5N,NCR
FR-FCM-ZZ5N,14B11
FR-FCM-ZZ5N,4D11
FR-FCM-ZZ5N,MCMV
FR-FCM-ZZ5X,Ly49G2
FR-FCM-ZZ5X,Ly49I/U
FR-FCM-ZZ5X,H-2k
FR-FCM-ZZ5X,MHC
FR-FCM-ZZ5X,NKC
FR-FCM-ZZ5X,NKp46
FR-FCM-ZZ5X,NCR
FR-FCM-ZZ5X,14B11
FR-FCM-ZZ5X,4D11
FR-FCM-ZZ5P,Ly49G2
FR-FCM-ZZ5P,Ly49I/U
FR-FCM-ZZ5P,H-2k
FR-FCM-ZZ5P,MHC
FR-FCM-ZZ5P,NKC
FR-FCM-ZZ5P,NKp46
FR-FCM-ZZ5P,NCR
FR-FCM-ZZ5P,14B11
FR-FCM-ZZ5P,4D11
FR-FCM-ZZ5P,MCMV
FR-FCM-ZZ5R,Ly49G2
FR-FCM-ZZ5R,Ly49I/U
FR-FCM-ZZ5R,H-2k
FR-FCM-ZZ5R,MHC
FR-FCM-ZZ5R,NKC
FR-FCM-ZZ5R,NKp46
FR-FCM-ZZ5R,NCR
FR-FCM-ZZ5R,14B11
FR-FCM-ZZ5R,4D11
FR-FCM-ZZ5R,MCMV
FR-FCM-ZZ5S,Ly49G2
FR-FCM-ZZ5S,Ly49I/U
FR-FCM-ZZ5S,H-2k
FR-FCM-ZZ5S,MHC
FR-FCM-ZZ5S,NKC
FR-FCM-ZZ5S,NKp46
FR-FCM-ZZ5S,NCR
FR-FCM-ZZ5S,14B11
FR-FCM-ZZ5S,4D11
FR-FCM-ZZ5T,Astrocytes
FR-FCM-ZZ5T,liposomes. myelin-lipids
FR-FCM-ZZ5T,CNS inflammation
FR-FCM-ZZ5U,liposomes
FR-FCM-ZZ5U,Astrocytes
FR-FCM-ZZ5U,HLA
FR-FCM-ZZ5V,Astrocytes
FR-FCM-ZZ5V,trypanosoma cruzi
FR-FCM-ZZ5V,HLA I
FR-FCM-ZZ5V,HLA II
FR-FCM-ZZ64,phycoerythrin; non-specific binding; plasma cells; intracellular staining
FR-FCM-ZZ65,FACS
FR-FCM-ZZ65,reporter
FR-FCM-ZZ65,sort
FR-FCM-ZZ65,high producer cells
FR-FCM-ZZ68,HIV
FR-FCM-ZZ68,flow cytometry
FR-FCM-ZZ68,Cell-cell fusion
FR-FCM-ZZ68,syncytia
FR-FCM-ZZ68,absolute cell counting
FR-FCM-ZZ69,HIV
FR-FCM-ZZ69,flow cytometry
FR-FCM-ZZ69,cell cycle
FR-FCM-ZZ69,Cell-cell fusion
FR-FCM-ZZ69,syncytia
FR-FCM-ZZ69,absolute cell counting
FR-FCM-ZZ6B,diffuse large B-cell lymphoma
FR-FCM-ZZ6B,hyperplasia
FR-FCM-ZZ6B,follicular lymphoma
FR-FCM-ZZ6D,Biodiesel crop; Flow Cytometry; Internal standardization; PI intercalation; Pongamia pinnata; Nuclear DNA content
FR-FCM-ZZ6E,Biodiesel crop; Flow Cytometry; Internal standardization; PI intercalation; Pongamia pinnata; Nuclear DNA content
FR-FCM-ZZ6W,flow cytometry
FR-FCM-ZZ6W,fluorescence
FR-FCM-ZZ6W,membrane integrity
FR-FCM-ZZ6W,light scattering
FR-FCM-ZZ6W,cryopreservation
FR-FCM-ZZ6W,cryobiology
FR-FCM-ZZ6W,cell gating
FR-FCM-ZZ6W,mitochondria
FR-FCM-ZZ6W,mitochondrial membrane potential
FR-FCM-ZZ6W,human umbilical vein endothelial cells (HUVEC)
FR-FCM-ZZ6K,flow cytometry
FR-FCM-ZZ6K,lymphocyte subsets
FR-FCM-ZZ6K,reference ranges
FR-FCM-ZZ6K,Oman
FR-FCM-ZZ6K,CD3+CD4+
FR-FCM-ZZ6K,CD3+CD8+
FR-FCM-ZZ6L,hematopoietic stem cells
FR-FCM-ZZ6L,ICS; standardization; reproducibility; positivity threshold; F-score; automated analysis
FR-FCM-ZZ6L,Rare event
FR-FCM-ZZ6R,GFP YFP
FR-FCM-ZZ72,C11-BODIPY581/591; oxidative stress; lipid peroxidation; green algae; Chlamydomonas reinhardtii;
FR-FCM-ZZ75,C11-BODIPY581/591; oxidative stress; lipid peroxidation; green algae; Chlamydomonas reinhardtii; Copper; Mercury; DDC; diuron
FR-FCM-ZZ7L,Plants
FR-FCM-ZZ7L,endoreduplication
FR-FCM-ZZ7L,C-value
FR-FCM-ZZ7N,Bacteria; E. coli; Cyanobacteria; Kinetic flow cytometry; real-time flow cytometry; algae
FR-FCM-ZZ7P,Immunophenotyping
FR-FCM-ZZ7P,flow cytometry; data analysis; statistical analysis; normalization
FR-FCM-ZZ7P,healthy controls
FR-FCM-ZZ7S,flow cytometry
FR-FCM-ZZ7S,Fluorescent proteins
FR-FCM-ZZ7S,Genetic barcoding
FR-FCM-ZZ7S,Retroviral technology
FR-FCM-ZZ7S,Multiplexing
FR-FCM-ZZ7S,high throughput capabilities
FR-FCM-ZZ7T,flow cytometry
FR-FCM-ZZ7T,Fluorescent proteins
FR-FCM-ZZ7T,Genetic barcoding
FR-FCM-ZZ7T,Retroviral technology
FR-FCM-ZZ7T,Multiplexing
FR-FCM-ZZ7T,high throughput capabilities
FR-FCM-ZZ7U,Intracellular cytokines; T cells; HIV; SIV; vaccines
FR-FCM-ZZ7V,flow cytometry
FR-FCM-ZZ7V,Fluorescent proteins
FR-FCM-ZZ7V,Genetic barcoding
FR-FCM-ZZ7V,Retroviral technology
FR-FCM-ZZ7V,Multiplexing
FR-FCM-ZZ7V,high throughput capabilities
FR-FCM-ZZ7V,cell based assay
FR-FCM-ZZ8Z,flow cytometry
FR-FCM-ZZ8Z,autoimmune hemolytic anemia
FR-FCM-ZZ8Z,erythrocytes
FR-FCM-ZZ8Z,immune complexes
FR-FCM-ZZ85,cystic fibrosis CFTR monocytes blocking peptide CD14
FR-FCM-ZZ88,flow cytometry
FR-FCM-ZZ88,genome size
FR-FCM-ZZ88,buffer
FR-FCM-ZZ88,fungi
FR-FCM-ZZ88,confocal microscopy
FR-FCM-ZZ88,RNAse
FR-FCM-ZZ88,fixation
FR-FCM-ZZ88,standard
FR-FCM-ZZ8F,Clustering
FR-FCM-ZZ8F,Human Mouse
FR-FCM-ZZ8F,SWIFT
FR-FCM-ZZ8F,Ground truth
FR-FCM-ZZ93,Activation markers
FR-FCM-ZZ93,basophils
FR-FCM-ZZ93,allergy
FR-FCM-ZZ9H,T-cells
FR-FCM-ZZ9H,Innate-like T-cell
FR-FCM-ZZ9H,MAIT cell
FR-FCM-ZZ9H,NKT cell
FR-FCM-ZZ9H,gammadelta T-cell
FR-FCM-ZZ9P,flow cytometry
FR-FCM-ZZ9P,fixation
FR-FCM-ZZ9P,EYFP
FR-FCM-ZZ9P,RFP
FR-FCM-ZZ9P,EGFP
FR-FCM-ZZ9P,FoxP3
FR-FCM-ZZ9P,RORγt
FR-FCM-ZZ9P,T-bet
FR-FCM-ZZ9P,fate mapping
FR-FCM-ZZ9P,formaldehyde
FR-FCM-ZZ9P,mouse T cells.
FR-FCM-ZZ9R,flow cytometry
FR-FCM-ZZ9R,Solid-state fermentation
FR-FCM-ZZ9R,basidiomycetes
FR-FCM-ZZ9R,biomass determination
FR-FCM-ZZ9R,nuclei
FR-FCM-ZZ9V,monocyte
FR-FCM-ZZ9V,CD14
FR-FCM-ZZ9V,Blood
FR-FCM-ZZ9V,leukocyte
FR-FCM-ZZ9V,lymphocyte
FR-FCM-ZZ9V,granulocyte
FR-FCM-ZZ9V,monocyte subpopulations
FR-FCM-ZZ9V,CD16
FR-FCM-ZZ9V,LRP1
FR-FCM-ZZ9V,atherosclerosis.
FR-FCM-ZZAZ,Intracellular Cytokine Staining
FR-FCM-ZZAZ,ICS
FR-FCM-ZZAZ,CMV
FR-FCM-ZZAZ,OMIP
FR-FCM-ZZAZ,tuberculosis
FR-FCM-ZZAZ,T cell memory
FR-FCM-ZZA3,flow cytometry
FR-FCM-ZZA3,meiotic prophase I
FR-FCM-ZZA3,Hoechst 33342
FR-FCM-ZZA3,Adult mouse testes
FR-FCM-ZZA3,cell sorting.
FR-FCM-ZZA4,flow cytometry
FR-FCM-ZZA4,basophils
FR-FCM-ZZA4,Blood
FR-FCM-ZZA4,asthma
FR-FCM-ZZA4,bronchoalveolar lavage
FR-FCM-ZZA4,chipcytometry
FR-FCM-ZZA8,IL17; IL22; mouse
FR-FCM-ZZA9,IL17; IL22; mouse; T cells
FR-FCM-ZZAA,human
FR-FCM-ZZAA,IL-22
FR-FCM-ZZAA,IL-17
FR-FCM-ZZAA,cord blood
FR-FCM-ZZAA,polarizing conditions
FR-FCM-ZZAD,mouse T cells
FR-FCM-ZZAD,IL17
FR-FCM-ZZAD,IL22
FR-FCM-ZZAD,KYA
FR-FCM-ZZAD,L-KYN
FR-FCM-ZZAD,laccase
FR-FCM-ZZAE,human
FR-FCM-ZZAE,aorta
FR-FCM-ZZAE,aneurysm
FR-FCM-ZZAE,stromal cells
FR-FCM-ZZAF,mouse T cells
FR-FCM-ZZAF,IL-22
FR-FCM-ZZAF,IL-17
FR-FCM-ZZAF,CA
FR-FCM-ZZAF,FICZ
FR-FCM-ZZAG,FoxP3
FR-FCM-ZZAG,mouse T cells
FR-FCM-ZZAG,CA
FR-FCM-ZZAG,Treg
FR-FCM-ZZAG,TGFb
FR-FCM-ZZAK,APOPTOSIS
FR-FCM-ZZAL,[Pacific oyster] [crassostrea gigas] [gamete quality] [ROS production] [viability] [flow cytometry] [ecotoxicology] [Alexandrium minutum] [Harmfull algal blooms] [oocytes]
FR-FCM-ZZAM,Treg
FR-FCM-ZZAM,Human naive T cells
FR-FCM-ZZAM,CFSE
FR-FCM-ZZAM,suppression
FR-FCM-ZZBD,human
FR-FCM-ZZBD,IL17
FR-FCM-ZZBD,IL22
FR-FCM-ZZBD,adult
FR-FCM-ZZBD,CD4 T cell
FR-FCM-ZZBF,Innate Immune Response
FR-FCM-ZZBF,Activation markers
FR-FCM-ZZBF,human neutrophils
FR-FCM-ZZBF,PD/PD-L1
FR-FCM-ZZBF,Mycobacteria
FR-FCM-ZZBG,IL17
FR-FCM-ZZBG,IL22
FR-FCM-ZZBG,human PBMCs
FR-FCM-ZZBG,stimulated
FR-FCM-ZZBJ,IL-22
FR-FCM-ZZBJ,human PBMCs
FR-FCM-ZZBJ,AHR antagonist
FR-FCM-ZZBJ,HAA
FR-FCM-ZZBK,human
FR-FCM-ZZBK,IL17
FR-FCM-ZZBK,IL22
FR-FCM-ZZBK,HAA
FR-FCM-ZZBK,CD4 T cells
FR-FCM-ZZBK,IFNg
FR-FCM-ZZBL,Mean Fluorescence Intensity (MFI)
FR-FCM-ZZBL,Beads
FR-FCM-ZZBL,microscopy
FR-FCM-ZZBN,Ancestral state reconstruction
FR-FCM-ZZBN,Mutation
FR-FCM-ZZBN,Evolution
FR-FCM-ZZBR,erythrocytes
FR-FCM-ZZBR,kurtosis
FR-FCM-ZZBR,shape
FR-FCM-ZZBS,CD25
FR-FCM-ZZBS,inmune innate
FR-FCM-ZZBS,invertebrate
FR-FCM-ZZBT,HIV
FR-FCM-ZZBT,Gene expression
FR-FCM-ZZBT,RNA Amplification
FR-FCM-ZZBT,RNA hybridization
FR-FCM-ZZBT,RNA Flow cytometry
FR-FCM-ZZC4,Gene expression
FR-FCM-ZZC4,RNA Amplification
FR-FCM-ZZC4,RNA hybridization
FR-FCM-ZZC4,RNA Flow cytometry
FR-FCM-ZZC7,monocyte
FR-FCM-ZZC7,PBMC
FR-FCM-ZZC7,CD4
FR-FCM-ZZC7,Gene expression
FR-FCM-ZZC7,RNA Flow cytometry
FR-FCM-ZZC8,PBMC
FR-FCM-ZZC8,CD4
FR-FCM-ZZC8,Gene expression
FR-FCM-ZZC8,stimulated
FR-FCM-ZZC8,RNA Flow cytometry
FR-FCM-ZZC9,PBMC
FR-FCM-ZZC9,CD4
FR-FCM-ZZC9,Gene expression
FR-FCM-ZZC9,RNA Flow cytometry
FR-FCM-ZZCA,CD44
FR-FCM-ZZCA,monocyte
FR-FCM-ZZCA,PBMC
FR-FCM-ZZCA,Gene expression
FR-FCM-ZZCA,RNA Flow cytometry
FR-FCM-ZZCB,PBMC
FR-FCM-ZZCB,Gene expression
FR-FCM-ZZCB,RNA Flow cytometry
FR-FCM-ZZCC,Gene expression
FR-FCM-ZZCC,RNA Amplification
FR-FCM-ZZCC,RNA hybridization
FR-FCM-ZZCC,RNA Flow cytometry
FR-FCM-ZZCD,Gene expression
FR-FCM-ZZCD,RNA Amplification
FR-FCM-ZZCD,RNA hybridization
FR-FCM-ZZCD,RNA Flow cytometry
FR-FCM-ZZCE,Gene expression
FR-FCM-ZZCE,RNA Amplification
FR-FCM-ZZCE,RNA hybridization
FR-FCM-ZZCE,RNA Flow cytometry
FR-FCM-ZZCF,Gene expression
FR-FCM-ZZCF,RNA Amplification
FR-FCM-ZZCF,RNA hybridization
FR-FCM-ZZCF,RNA Flow cytometry
FR-FCM-ZZD7,human
FR-FCM-ZZD7,CD4 T cell
FR-FCM-ZZD7,Streptococcus pneumoniae
FR-FCM-ZZD7,IL-17A
FR-FCM-ZZD7,alveolar macrophage
FR-FCM-ZZD7,Lung cells
FR-FCM-ZZD7,Vaccine
FR-FCM-ZZD7,experimental human pneumococcal carriage
FR-FCM-ZZD7,BAL
FR-FCM-ZZD7,TNF
FR-FCM-ZZD7,IL-17RA
FR-FCM-ZZD7,IL-17RC
FR-FCM-ZZD7,phagocytosis
FR-FCM-ZZD7,serotype 6B
FR-FCM-ZZD7,intra-cellular cytokine staining
FR-FCM-ZZD7,IFNgamma
FR-FCM-ZZD7,Influenza
FR-FCM-ZZD8,yeast; cell cycle; size control
FR-FCM-ZZD9,cell cycle
FR-FCM-ZZD9,budding yeast
FR-FCM-ZZDA,yeast; cell cycle; size control
FR-FCM-ZZDB,yeast; cell cycle; size control
FR-FCM-ZZDE,CD4
FR-FCM-ZZDE,Cytokine secretion assay
FR-FCM-ZZDE,IL-2
FR-FCM-ZZDK,Acute Myeloid Leukemia
FR-FCM-ZZDK,multicolor flow cytometry
FR-FCM-ZZDK,signaling
FR-FCM-ZZDX,CD4
FR-FCM-ZZDX,IL-2
FR-FCM-ZZDX,Cyotkine secretion assay
FR-FCM-ZZDP,CD4
FR-FCM-ZZDP,Cytokine secretion assay
FR-FCM-ZZDP,IL-2
FR-FCM-ZZDQ,lymphocyte subsets
FR-FCM-ZZDQ,reference values
FR-FCM-ZZDQ,pediatric population
FR-FCM-ZZDQ,primary immunodeficiencies.
FR-FCM-ZZDR,flow cytometry
FR-FCM-ZZDR,Rhabdomyosarcoma
FR-FCM-ZZDR,PAX3
FR-FCM-ZZDR,minimal residual disease
FR-FCM-ZZDR,soft tissue sarcomas
FR-FCM-ZZDR,pediatric cancer.
FR-FCM-ZZDS,flow cytometry
FR-FCM-ZZDS,Rhabdomyosarcoma
FR-FCM-ZZDS,PAX3
FR-FCM-ZZDS,minimal residual disease
FR-FCM-ZZDS,soft tissue sarcomas
FR-FCM-ZZDS,pediatric cancer
FR-FCM-ZZEB,B cells
FR-FCM-ZZEB,NK cells
FR-FCM-ZZEB,monocytes
FR-FCM-ZZEB,Phenotyping
FR-FCM-ZZEB,human PBMC
FR-FCM-ZZEB,T cells
FR-FCM-ZZEB,γδ T cells
FR-FCM-ZZEB,activation
FR-FCM-ZZEB,differentiation
FR-FCM-ZZEC,Intracellular Cytokine Staining
FR-FCM-ZZEC,NK cells
FR-FCM-ZZEC,human PBMC
FR-FCM-ZZEC,T cells
FR-FCM-ZZEC,TFH cells
FR-FCM-ZZEC,memory
FR-FCM-ZZED,CyTOF; mass cytometry; flow cytometry; standardization; immune-monitoring; mouse
FR-FCM-ZZEK,Pseudomonas putida
FR-FCM-ZZEK,DNA content
FR-FCM-ZZEK,DAPI
FR-FCM-ZZEL,histamine H4 receptor
FR-FCM-ZZEL,BODIPY® FL Histamine
FR-FCM-ZZEL,mast cells
FR-FCM-ZZEM,cryopreservation
FR-FCM-ZZEM,multimer comparison
FR-FCM-ZZEM,quality assurance
FR-FCM-ZZEM,MHC multimer
FR-FCM-ZZEM,Cryoprotectant
FR-FCM-ZZEM,Glycerol in T cell staining
FR-FCM-ZZEN,BDL
FR-FCM-ZZEN,clodronate
FR-FCM-ZZEU,GFP
FR-FCM-ZZEU,leukocyte
FR-FCM-ZZEU,Adult mouse
FR-FCM-ZZEU,bronchoalveolar lavage
FR-FCM-ZZF2,nanoparticle
FR-FCM-ZZF2,normal cells
FR-FCM-ZZF2,multidimension data
FR-FCM-ZZG3,flow cytometry
FR-FCM-ZZG3,episome
FR-FCM-ZZG3,expression kinetics
FR-FCM-ZZG3,integration-deficient
FR-FCM-ZZG3,proliferation rate
FR-FCM-ZZG3,protein half-life
FR-FCM-ZZG3,retroviral vector
FR-FCM-ZZG3,transient gene expression
FR-FCM-ZZG4,Notch
FR-FCM-ZZG4,differentiation
FR-FCM-ZZG4,leukemic cell
FR-FCM-ZZG4,ATRA
FR-FCM-ZZG4,PMA
FR-FCM-ZZG6,data analysis
FR-FCM-ZZG6,gate setting
FR-FCM-ZZG6,2D-histogram evaluation
FR-FCM-ZZG6,microbial communities
FR-FCM-ZZG8,multi-parametric flow cytometry
FR-FCM-ZZG8,automated analysis
FR-FCM-ZZG8,population annotation with heatmaps
FR-FCM-ZZGB,microbiome resource management
FR-FCM-ZZGB,bioelectrochemical system
FR-FCM-ZZGB,biogas
FR-FCM-ZZGB,anaerobic digestion
FR-FCM-ZZGB,microbial community
FR-FCM-ZZGB,mixed culture biotechnology
FR-FCM-ZZGC,automated gating
FR-FCM-ZZGC,T cell
FR-FCM-ZZGC,lymphocyte subsets
FR-FCM-ZZGM,microparticles
FR-FCM-ZZGM,Standardization
FR-FCM-ZZGM,FSC
FR-FCM-ZZGM,SSC
FR-FCM-ZZGM,Megamix
FR-FCM-ZZGM,inter platform reproducibility
FR-FCM-ZZGN,liposomes
FR-FCM-ZZGN,vesicles
FR-FCM-ZZGN,di-8-ANEPPS
FR-FCM-ZZGX,Extracellular vesicles
FR-FCM-ZZGX,microvesicles
FR-FCM-ZZGX,micropartices
FR-FCM-ZZGX,rat
FR-FCM-ZZGX,platelets
FR-FCM-ZZGX,platelet-rich plasma
FR-FCM-ZZGX,PRP
FR-FCM-ZZGR,FRET
FR-FCM-ZZGR,biosensor
FR-FCM-ZZGR,HEK293T
FR-FCM-ZZGR,fluorescence lifetime
FR-FCM-ZZGR,FRET standard
FR-FCM-ZZGS,Clustering
FR-FCM-ZZGS,SWIFT
FR-FCM-ZZGS,Young
FR-FCM-ZZGS,Elderly
FR-FCM-ZZGS,Old
FR-FCM-ZZGS,Template
FR-FCM-ZZGS,Competition
FR-FCM-ZZGT,gold nanoparticles
FR-FCM-ZZGT,cancer cells
FR-FCM-ZZGT,static magnetic field
FR-FCM-ZZGT,multidimensional clustering
FR-FCM-ZZGU,cancer cells
FR-FCM-ZZGU,iron oxide nanoparticles
FR-FCM-ZZGU,static magneti field
FR-FCM-ZZGU,statistical clustering
FR-FCM-ZZWB,MACS
FR-FCM-ZZWB,depletion
FR-FCM-ZZWB,microbeads
FR-FCM-ZZWC,mass cytometry
FR-FCM-ZZWC,CyTOF
FR-FCM-ZZWC,immunoclust
FR-FCM-ZZWG,fluorescence
FR-FCM-ZZWG,fIbroblast
FR-FCM-ZZWG,Conjugated polyelectrolyte
FR-FCM-ZZWG,luminescent conjugated polythiophene
FR-FCM-ZZWG,melanoma
FR-FCM-ZZWM,flow cytometry
FR-FCM-ZZWM,Adhesion molecule
FR-FCM-ZZWM,Brain microvascular endothelium
FR-FCM-ZZWM,Leukocyte-Endothelial cell interaction
FR-FCM-ZZWM,Adhesion
FR-FCM-ZZWX,CRISPR
FR-FCM-ZZWX,zebrafish
FR-FCM-ZZWX,urod
FR-FCM-ZZWU,human
FR-FCM-ZZWU,CD4+ T cells
FR-FCM-ZZWU,PBMCs
FR-FCM-ZZWU,T helper
FR-FCM-ZZWU,T cell subsets
FR-FCM-ZZWU,mNKT/MAIT cells
FR-FCM-ZZJ5,flow cytometry
FR-FCM-ZZJ5,Immunophenotyping
FR-FCM-ZZJ5,Beads
FR-FCM-ZZJ5,Compensation
FR-FCM-ZZJ5,Polystyrene Microspheres
FR-FCM-ZZJ5,Polychromatic
FR-FCM-ZZJ5,Leukocytes
FR-FCM-ZZJ6,Mesechymal stem cell
FR-FCM-ZZJ6,Organ Culture
FR-FCM-ZZJ6,High content imaging
FR-FCM-ZZJ7,GvHD
FR-FCM-ZZJ7,DAPI
FR-FCM-ZZJ7,FlowRepositoryR
FR-FCM-ZZJB,fertilization
FR-FCM-ZZJB,mating
FR-FCM-ZZJB,bi-molecular complementation
FR-FCM-ZZJB,Saccharomyces cerevisiae
FR-FCM-ZZJH,fertilization
FR-FCM-ZZJH,mating
FR-FCM-ZZJH,bi-molecular complementation
FR-FCM-ZZJH,Saccharomyces cerevisiae
FR-FCM-ZZJL,fertilization
FR-FCM-ZZJL,mating
FR-FCM-ZZJL,bi-molecular complementation
FR-FCM-ZZJL,Saccharomyces cerevisiae
FR-FCM-ZZJM,fertilization
FR-FCM-ZZJM,mating
FR-FCM-ZZJM,bi-molecular complementation
FR-FCM-ZZJM,Saccharomyces cerevisiae
FR-FCM-ZZJN,fertilization
FR-FCM-ZZJN,mating
FR-FCM-ZZJN,bi-molecular complementation
FR-FCM-ZZJN,Saccharomyces cerevisiae
FR-FCM-ZZJX,fertilization
FR-FCM-ZZJX,mating
FR-FCM-ZZJX,bi-molecular complementation
FR-FCM-ZZJX,Saccharomyces cerevisiae
FR-FCM-ZZJP,fertilization
FR-FCM-ZZJP,mating
FR-FCM-ZZJP,bi-molecular complementation
FR-FCM-ZZJP,Saccharomyces cerevisiae
FR-FCM-ZZJR,fertilization
FR-FCM-ZZJR,mating
FR-FCM-ZZJR,bi-molecular complementation
FR-FCM-ZZJR,Saccharomyces cerevisiae
FR-FCM-ZZJS,fertilization
FR-FCM-ZZJS,mating
FR-FCM-ZZJS,bi-molecular complementation
FR-FCM-ZZJS,Saccharomyces cerevisiae
FR-FCM-ZZJT,fertilization
FR-FCM-ZZJT,mating
FR-FCM-ZZJT,bi-molecular complementation
FR-FCM-ZZJT,Saccharomyces cerevisiae
FR-FCM-ZZKZ,mass cytometry
FR-FCM-ZZKZ,machine learning
FR-FCM-ZZKZ,computational biology
FR-FCM-ZZKZ,viSNE
FR-FCM-ZZKZ,SPADE
FR-FCM-ZZKZ,heatmaps
FR-FCM-ZZK3,ice-shelf
FR-FCM-ZZK3,biogeochemistry
FR-FCM-ZZK3,McMurdo Ice Shelf
FR-FCM-ZZK3,Ross Ice Shelf
FR-FCM-ZZK3,Southern Ocean
FR-FCM-ZZK3,Antarctica
FR-FCM-ZZK4,NK cells
FR-FCM-ZZK4,KIR3DL05
FR-FCM-ZZK4,KIR3DL01
FR-FCM-ZZK4,Rhesus macaque
FR-FCM-ZZK9,Arthritis
FR-FCM-ZZK9,cell surface markers
FR-FCM-ZZK9,protoporphyrin IX
FR-FCM-ZZK9,synovial mesenchymal stem cells
FR-FCM-ZZKA,Ground truth
FR-FCM-ZZKA,simulated data
FR-FCM-ZZKH,flow cytometry
FR-FCM-ZZKH,MHC multimer
FR-FCM-ZZKH,CD8 T cells
FR-FCM-ZZKH,HLA-B molecules
FR-FCM-ZZKH,conditional ligands
FR-FCM-ZZLY,bradykinin
FR-FCM-ZZLY,Neural Progenitor Cells
FR-FCM-ZZLY,Neurogenesis
FR-FCM-ZZLY,and Proliferation.
FR-FCM-ZZL3,Embryonic stem cells
FR-FCM-ZZL3,Undifferentiated cell marker
FR-FCM-ZZL3,bradykinin
FR-FCM-ZZL3,neural differentiation
FR-FCM-ZZLF,flow cytometry
FR-FCM-ZZLF,Titration
FR-FCM-ZZLF,Chlamydia suis
FR-FCM-ZZLF,Hep2
FR-FCM-ZZLG,FACS
FR-FCM-ZZLG,confocal microscopy
FR-FCM-ZZLG,Chlamydia suis
FR-FCM-ZZLG,Hep2
FR-FCM-ZZLG,cytospin
FR-FCM-ZZLH,T cells
FR-FCM-ZZLH,scleroderma
FR-FCM-ZZLH,immune response
FR-FCM-ZZLP,mass cytometry
FR-FCM-ZZLP,CyTOF
FR-FCM-ZZLP,platinum
FR-FCM-ZZLV,flow cytometry
FR-FCM-ZZLV,data analysis
FR-FCM-ZZLV,R
FR-FCM-ZZMY,DNA ploidy
FR-FCM-ZZMY,FxCycle Violet
FR-FCM-ZZMY,surface immunophenotyping
FR-FCM-ZZM3,Rare event
FR-FCM-ZZM3,FxCycle Violet
FR-FCM-ZZM3,Simultaneous six color surface staining & DNA ploidy
FR-FCM-ZZM4,Simultaneous six color surface staining & DNA ploidy
FR-FCM-ZZM4,B-ALL
FR-FCM-ZZM4,MRD
FR-FCM-ZZM5,FxCycle Violet
FR-FCM-ZZM5,Simultaneous six color surface staining & DNA ploidy
FR-FCM-ZZM5,Intra-assay variation
FR-FCM-ZZM8,FxCycle Violet
FR-FCM-ZZM8,Simultaneous six color surface staining & DNA ploidy
FR-FCM-ZZM8,multiple myeloma
FR-FCM-ZZMC,mass cytometry
FR-FCM-ZZMC,AML
FR-FCM-ZZMW,Sperm
FR-FCM-ZZMW,zebrafish
FR-FCM-ZZMW,Concentration
FR-FCM-ZZMJ,CD200
FR-FCM-ZZMJ,CD200R
FR-FCM-ZZMJ,Mincle
FR-FCM-ZZML,Monocyte subpopulation
FR-FCM-ZZML,acute exercise
FR-FCM-ZZML,metabolic syndrome
FR-FCM-ZZMX,Extracellular vesicles
FR-FCM-ZZMX,exosome
FR-FCM-ZZMX,microvesicle
FR-FCM-ZZMX,microparticle
FR-FCM-ZZMX,liposome
FR-FCM-ZZNA,microbial communities
FR-FCM-ZZNA,microbiome resource management
FR-FCM-ZZNA,microbiology
FR-FCM-ZZNV,human PBMCs
FR-FCM-ZZNV,visualiztion
FR-FCM-ZZNV,peripheral blood profiling kit (fluidigm)
FR-FCM-ZZXY,Population Identification
FR-FCM-ZZXY,hematopoietic stem cells
FR-FCM-ZZXY,Immunophenotyping
FR-FCM-ZZX2,Population Identification
FR-FCM-ZZX2,hematopoietic stem cells
FR-FCM-ZZX4,Beads
FR-FCM-ZZX4,LED pulse
FR-FCM-ZZX4,multispectral
FR-FCM-ZZX4,Q
FR-FCM-ZZX4,B
FR-FCM-ZZX6,monocytes
FR-FCM-ZZX6,macrophage polarization
FR-FCM-ZZX6,dexamethasone
FR-FCM-ZZX7,monocytes
FR-FCM-ZZX7,macrophage polarization
FR-FCM-ZZX7,dexamethasone
FR-FCM-ZZX8,FLOW-FISH
FR-FCM-ZZX8,telomere
FR-FCM-ZZX9,KIR3DL05
FR-FCM-ZZX9,KIR3DL01
FR-FCM-ZZX9,Rhesus macaque
FR-FCM-ZZX9,NK cell functions
FR-FCM-ZZP6,flow cytometry
FR-FCM-ZZP6,microbial communities
FR-FCM-ZZP6,Microbiota
FR-FCM-ZZP6,colitis
FR-FCM-ZZP8,flow cytometry
FR-FCM-ZZP8,microbial communities
FR-FCM-ZZP8,Microbiota
FR-FCM-ZZPA,Yeast
FR-FCM-ZZPA,galactose
FR-FCM-ZZPA,GAL
FR-FCM-ZZPA,dynamic gene expression
FR-FCM-ZZPA,GFP reporter
FR-FCM-ZZPA,DOT6
FR-FCM-ZZPB,1001genomes
FR-FCM-ZZPB,AFB
FR-FCM-ZZPB,TIR1
FR-FCM-ZZPB,AFB2
FR-FCM-ZZPB,natural variation
FR-FCM-ZZPB,steady state
FR-FCM-ZZPC,iPSC-derived Neural Stem/Progenitor cells
FR-FCM-ZZQ7,HEK293 cells
FR-FCM-ZZQ7,WGA
FR-FCM-ZZQ7,wheat germ agglutinin
FR-FCM-ZZQ8,WGA
FR-FCM-ZZQ8,wheat germ agglutinin
FR-FCM-ZZQ8,U87
FR-FCM-ZZQ8,cell size
FR-FCM-ZZQ9,human PBMC
FR-FCM-ZZQ9,WGA
FR-FCM-ZZQ9,wheat germ agglutinin
FR-FCM-ZZQ9,cell size
FR-FCM-ZZQA,whole blood
FR-FCM-ZZQA,CyTOF
FR-FCM-ZZQA,WGA
FR-FCM-ZZQA,wheat germ agglutinin
FR-FCM-ZZQA,cell size
FR-FCM-ZZQB,whole blood
FR-FCM-ZZQB,CyTOF
FR-FCM-ZZQB,WGA
FR-FCM-ZZQB,wheat germ agglutinin
FR-FCM-ZZQB,cell size
FR-FCM-ZZQC,whole blood
FR-FCM-ZZQC,CyTOF
FR-FCM-ZZQC,WGA
FR-FCM-ZZQC,wheat germ agglutinin
FR-FCM-ZZQC,cell siz
FR-FCM-ZZQM,reporter
FR-FCM-ZZQM,Fluorescent proteins
FR-FCM-ZZQM,EGFP
FR-FCM-ZZQM,plasmid
FR-FCM-ZZQM,plasmid copy number
FR-FCM-ZZQM,Heterologous expression
FR-FCM-ZZQM,Escherichia coli
FR-FCM-ZZQM,replication system
FR-FCM-ZZQX,DAPI
FR-FCM-ZZQX,WWTP
FR-FCM-ZZQX,metacommunity
FR-FCM-ZZQX,primary clarifier
FR-FCM-ZZQX,primary sludge
FR-FCM-ZZQX,aeration tank
FR-FCM-ZZQX,excess sludge
FR-FCM-ZZQX,anaerobic digester
FR-FCM-ZZQX,anaerobic digester centrate
FR-FCM-ZZQQ,whole blood
FR-FCM-ZZQQ,mass cytometry
FR-FCM-ZZQQ,CyTOF
FR-FCM-ZZQQ,Leukocytes
FR-FCM-ZZQQ,innate myeloid immunity
FR-FCM-ZZR6,T cells
FR-FCM-ZZR6,FRET
FR-FCM-ZZR6,T cell activation
FR-FCM-ZZRA,GFP
FR-FCM-ZZRA,yEGFP3
FR-FCM-ZZRQ,monocytes
FR-FCM-ZZRQ,myeloid dendritic cells
FR-FCM-ZZRQ,CD1c
FR-FCM-ZZRS,monocyte
FR-FCM-ZZRS,myeloid dendritic cells
FR-FCM-ZZRS,CD1c
FR-FCM-ZZRS,dendritic cells
FR-FCM-ZZRT,CD14
FR-FCM-ZZRT,monocytes
FR-FCM-ZZRT,myeloid dendritic cells
FR-FCM-ZZRT,CD1c
FR-FCM-ZZRV,monocytes
FR-FCM-ZZRV,CD4 T cells
FR-FCM-ZZRV,dendritic cells
FR-FCM-ZZRV,coculture
FR-FCM-ZZRV,MLR
FR-FCM-ZZS3,flow cytometry
FR-FCM-ZZS3,APOPTOSIS
FR-FCM-ZZS3,multiparametric analysis
FR-FCM-ZZS3,DNA damage
FR-FCM-ZZS3,proliferation
FR-FCM-ZZS3,click chemistry
FR-FCM-ZZS3,cancer stem cell markers
FR-FCM-ZZSC,T cell
FR-FCM-ZZSC,NK cells
FR-FCM-ZZSC,OMIP
FR-FCM-ZZSC,checkpoin inhibitors
FR-FCM-ZZSG,flow cytometry
FR-FCM-ZZSG,microbial communities
FR-FCM-ZZSG,microbiology
FR-FCM-ZZSH,flow cytometry
FR-FCM-ZZSH,microbiology
FR-FCM-ZZSQ,whole blood
FR-FCM-ZZSQ,human
FR-FCM-ZZSQ,mass cytometry
FR-FCM-ZZSQ,CyTOF
FR-FCM-ZZSQ,Leukocytes
FR-FCM-ZZSQ,innate myeloid immunity
FR-FCM-ZZSQ,macaque
FR-FCM-ZZSR,whole blood
FR-FCM-ZZSR,human
FR-FCM-ZZSR,mass cytometry
FR-FCM-ZZSR,CyTOF
FR-FCM-ZZSR,Leukocytes
FR-FCM-ZZSR,innate myeloid immunity
FR-FCM-ZZSR,macaque
FR-FCM-ZZTY,HIV
FR-FCM-ZZTY,bronchoalveolar lavage
FR-FCM-ZZTY,CyTOF; mass cytometry; flow cytometry; standardization
FR-FCM-ZZTY,human immunology
FR-FCM-ZZT8,cytosine methylation
FR-FCM-ZZT8,DNA damage
FR-FCM-ZZTF,B (background light level).
FR-FCM-ZZTF,Instrument Sensitivity
FR-FCM-ZZTF,LED pulse
FR-FCM-ZZTF,Q and B calculation
FR-FCM-ZZTF,multi-level beads
FR-FCM-ZZTW,signaling
FR-FCM-ZZTW,basophils
FR-FCM-ZZTW,allergy
FR-FCM-ZZTW,whole blood
FR-FCM-ZZTW,whole blood intracellular staining
FR-FCM-ZZTW,pediatric population
FR-FCM-ZZTW,mass cytometry
FR-FCM-ZZTW,CyTOF
FR-FCM-ZZTW,CD63
FR-FCM-ZZTW,platelet-basophil aggregates
FR-FCM-ZZTJ,mass cytometry
FR-FCM-ZZTJ,freezing
FR-FCM-ZZTJ,cellular surface markers
FR-FCM-ZZTJ,intracellular staining
FR-FCM-ZZTK,anti-fibroblast
FR-FCM-ZZTK,fibroblast activation protein α
FR-FCM-ZZTK,fibroblast surface protein
FR-FCM-ZZTK,epithelial-to-mesenchymal transition
FR-FCM-ZZTK,cancer-associated fibroblasts
FR-FCM-ZZTN,Imaging Flow cytometry
FR-FCM-ZZTN,Time-lapse microscopy
FR-FCM-ZZTN,label-free
FR-FCM-ZZTN,dynamic phenotype
FR-FCM-ZZTN,morphology
FR-FCM-ZZTP,CyTOF
FR-FCM-ZZTP,cell size
FR-FCM-ZZTP,oso4
FR-FCM-ZZTQ,human PBMCs
FR-FCM-ZZTQ,CyTOF
FR-FCM-ZZTQ,WGA
FR-FCM-ZZTQ,cell size
FR-FCM-ZZTQ,oso4
FR-FCM-ZZTQ,human lung tissue
FR-FCM-ZZTR,pFYS018
FR-FCM-ZZTR,surface display
FR-FCM-ZZTR,lpp-ompA
FR-FCM-ZZTS,surface display
FR-FCM-ZZTS,lpp-ompA
FR-FCM-ZZTS,pFYS019
FR-FCM-ZZTT,surface display
FR-FCM-ZZTT,lpp-ompA
FR-FCM-ZZTT,pFYS028
FR-FCM-ZZU3,THP1
FR-FCM-ZZU3,NFkB
FR-FCM-ZZU3,nuclear localization
FR-FCM-ZZU4,LPS
FR-FCM-ZZU4,human PBMCs
FR-FCM-ZZU4,TNF
FR-FCM-ZZU4,NFkB
FR-FCM-ZZU7,heterogeneity
FR-FCM-ZZU7,Silver nanoparticles
FR-FCM-ZZU7,silver ions
FR-FCM-ZZU7,microbial flow cytometry
FR-FCM-ZZU7,toxicity of silver nanoparticles on bacteria
FR-FCM-ZZUB,PBMC
FR-FCM-ZZUB,LPS
FR-FCM-ZZUB,TNF
FR-FCM-ZZUB,NFkB
FR-FCM-ZZUC,cell cycle
FR-FCM-ZZUC,DNA damage
FR-FCM-ZZUC,BRCA1
FR-FCM-ZZUR,Babesia
FR-FCM-ZZUR,FACSDiva
FR-FCM-ZZUR,Vybrant®DyeCycle Green dye
FR-FCM-ZZUS,monocyte
FR-FCM-ZZUS,TNF
FR-FCM-ZZUS,NFkB
FR-FCM-ZZUT,PBMC
FR-FCM-ZZUT,monocytes
FR-FCM-ZZUT,mitochondria
FR-FCM-ZZUT,Lymphocytes
FR-FCM-ZZUU,human PBMCs
FR-FCM-ZZUU,PMA
FR-FCM-ZZUU,ionomycin
FR-FCM-ZZUU,NFAT
FR-FCM-ZZUV,PBMC
FR-FCM-ZZUV,PMA
FR-FCM-ZZUV,ionomycin
FR-FCM-ZZUV,NFAT
FR-FCM-ZZVZ,SYBR Green I
FR-FCM-ZZVZ,Babesia
FR-FCM-ZZVZ,Vybrant®DyeCycleTMGreen dye
FR-FCM-ZZVZ,FACSDiva
FR-FCM-ZZVY,PBMCs
FR-FCM-ZZVY,NFkB
FR-FCM-ZZVY,IkBa
FR-FCM-ZZVY,Proximity Ligation Assay
FR-FCM-ZZV2,DNA damage
FR-FCM-ZZV2,BRCA1
FR-FCM-ZZV2,pH2AX
FR-FCM-ZZV2,ionizing
FR-FCM-ZZV4,DNA damage
FR-FCM-ZZV4,BRCA1
FR-FCM-ZZV4,Proximity Ligation Assay
FR-FCM-ZZV4,pH2AX
FR-FCM-ZZV6,DNA damage
FR-FCM-ZZV6,BRCA1
FR-FCM-ZZV6,Proximity Ligation Assay
FR-FCM-ZZV6,pH2AX
FR-FCM-ZZV7,DNA damage
FR-FCM-ZZV7,BRCA1
FR-FCM-ZZV7,Proximity Ligation Assay
FR-FCM-ZZV7,pH2AX
FR-FCM-ZZVD,Babesia
FR-FCM-ZZVD,FACSDiva
FR-FCM-ZZVD,Vybrant®DyeCycle Green dye
FR-FCM-ZZVD,ALLN
FR-FCM-ZZVE,Babesia
FR-FCM-ZZVE,FACSDiva
FR-FCM-ZZVE,ALLN
FR-FCM-ZZVE,Vybrant DyeCycle Green dye
FR-FCM-ZZVF,Babesia
FR-FCM-ZZVF,FACSDiva
FR-FCM-ZZVF,ALLN
FR-FCM-ZZVF,Vybrant DyeCycle Green dye
FR-FCM-ZZVG,Babesia
FR-FCM-ZZVG,FACSDiva
FR-FCM-ZZVG,Vybrant DyeCycle Green dye
FR-FCM-ZZVG,neuraminidase
FR-FCM-ZZVH,Babesia
FR-FCM-ZZVH,FACSDiva
FR-FCM-ZZVH,Vybrant DyeCycle Green dye
FR-FCM-ZZVH,EGTA
FR-FCM-ZZVH,egress
FR-FCM-ZZVL,CD45 isoforms
FR-FCM-ZZVL,PAG KO mice
FR-FCM-ZZVR,c-Cbl Cbl-b DKO mice
FR-FCM-ZZVR,naive and effector/memory CD4+ T cells
FR-FCM-ZZVU,B cells
FR-FCM-ZZVU,follicular lymphoma
FR-FCM-ZZVU,mass cytometry
FR-FCM-ZZVU,CyTOF
FR-FCM-ZZVU,viSNE
FR-FCM-ZYZA,Bacteria
FR-FCM-ZYZA,bacterioplankton
FR-FCM-ZYZA,microbial com
FR-FCM-ZYZE,macrophage
FR-FCM-ZYZG,proliferation
FR-FCM-ZYZG,macrophage
FR-FCM-ZYZG,frog
FR-FCM-ZYZG,Xenopus
FR-FCM-ZYZG,self-renewal
FR-FCM-ZYZN,Bacteria
FR-FCM-ZYZN,microbial community
FR-FCM-ZYZN,bacterioplankton
FR-FCM-ZYZX,mass cytometry
FR-FCM-ZYZX,CyTOF
FR-FCM-ZYZX,innate immunity
FR-FCM-ZYZX,tSNE
FR-FCM-ZYY6,CMV
FR-FCM-ZYY6,NK cells
FR-FCM-ZYY6,NK receptors
FR-FCM-ZYY6,NKG2C
FR-FCM-ZYY6,adaptive NK cells
FR-FCM-ZY23,FDG
FR-FCM-ZY23,Katuskha
FR-FCM-ZY23,cis and trans reporters
FR-FCM-ZY24,Intracellular cytokines; CD8 T cells
FR-FCM-ZY24,IFNg
FR-FCM-ZY24,ESX-1
FR-FCM-ZY24,TNFa
FR-FCM-ZY2B,membrane integrity
FR-FCM-ZY2B,SYTOX Green
FR-FCM-ZY2B,green fluorescence
FR-FCM-ZY2E,quantiFlash
FR-FCM-ZY2E,instrument characterization
FR-FCM-ZY2E,dynamic range
FR-FCM-ZY2E,signal-to-noise
FR-FCM-ZY2V,kinetic flow cytometry
FR-FCM-ZY2V,Bacteria
FR-FCM-ZY2V,real-time flow cytometry
FR-FCM-ZY3Z,flow cytometry
FR-FCM-ZY3Z,mass cytometry
FR-FCM-ZY3Z,CyTOF
FR-FCM-ZY3Z,Standardization
FR-FCM-ZY34,flow cytometry
FR-FCM-ZY34,mass cytometry
FR-FCM-ZY34,PD-1
FR-FCM-ZY34,biomarker prediction
FR-FCM-ZY34,immunotherapy
FR-FCM-ZY34,immune signature
FR-FCM-ZY36,T cell
FR-FCM-ZY36,cell surface markers
FR-FCM-ZY36,Chagas disease
FR-FCM-ZY3E,Adult Stem Cells
FR-FCM-ZY3E,Skeletal Muscle
FR-FCM-ZY3E,Progenitor Cells
FR-FCM-ZY3E,Homeostasis
FR-FCM-ZY3F,Adult Stem Cells
FR-FCM-ZY3F,CyTOF
FR-FCM-ZY3F,injured cells
FR-FCM-ZY3F,Skeletal Muscle
FR-FCM-ZY3F,Progenitor Cells
FR-FCM-ZY3G,Adult Stem Cells
FR-FCM-ZY3G,CyTOF
FR-FCM-ZY3G,Skeletal Muscle
FR-FCM-ZY3G,Progenitor Cells
FR-FCM-ZY3G,Muta
FR-FCM-ZY3H,Adult Stem Cells
FR-FCM-ZY3H,Mutation
FR-FCM-ZY3H,CyTOF
FR-FCM-ZY3H,Skeletal Muscle
FR-FCM-ZY3H,Progenitor Cells
FR-FCM-ZY3W,Adult Stem Cells
FR-FCM-ZY3W,CyTOF
FR-FCM-ZY3W,Skeletal Muscle
FR-FCM-ZY3W,Progenitor Cells
FR-FCM-ZY3J,Adult Stem Cells
FR-FCM-ZY3J,Mutation
FR-FCM-ZY3J,CyTOF
FR-FCM-ZY3J,Skeletal Muscle
FR-FCM-ZY3J,Progenitor Cells
FR-FCM-ZY3K,Adult Stem Cells
FR-FCM-ZY3K,CyTOF
FR-FCM-ZY3K,Skeletal Muscle
FR-FCM-ZY3K,Progenitor Cells
FR-FCM-ZY3K,Injure
FR-FCM-ZY3M,flow cytometry
FR-FCM-ZY3M,Immunophenotyping
FR-FCM-ZY3M,fluorescent cell barcoding
FR-FCM-ZY3M,viability dye
FR-FCM-ZY3S,Wilms’ tumor antigen (WT1)
FR-FCM-ZY3S,antigen-specific CD8+ T cells
FR-FCM-ZY3S,MHC Streptamer
FR-FCM-ZY3S,singleplatform
FR-FCM-ZY3T,cancer stem cells
FR-FCM-ZY3T,Sox9
FR-FCM-ZY3T,hepatic progenitor cells
FR-FCM-ZY3T,liver
FR-FCM-ZY3T,URI mouse model
FR-FCM-ZY3T,HCC
FR-FCM-ZY3T,Adenomas
FR-FCM-ZY3V,APOPTOSIS
FR-FCM-ZY3V,mouse T cells
FR-FCM-ZY3V,IFNg
FR-FCM-ZY3V,CD 4 T cells
FR-FCM-ZY3V,Th0
FR-FCM-ZY3V,Th1
FR-FCM-ZY3V,4sU-labeling
FR-FCM-ZY4Z,monocytes
FR-FCM-ZY4Z,LPS
FR-FCM-ZY4Z,FoxP3
FR-FCM-ZY4Z,IL-2
FR-FCM-ZY4Z,T cells
FR-FCM-ZY4Z,nuclear localization
FR-FCM-ZY4Z,NF-kB
FR-FCM-ZY4Z,Subcellular Localization
FR-FCM-ZY4Z,Cell Signaling
FR-FCM-ZY4Z,RelA
FR-FCM-ZY4Z,STAT5
FR-FCM-ZY4Z,Tregs
FR-FCM-ZY4Z,regulatory T cells
FR-FCM-ZY46,autofluorescence
FR-FCM-ZY46,process monitoring
FR-FCM-ZY46,biogas
FR-FCM-ZY46,anaerobic digestion
FR-FCM-ZY46,single cell analytics
FR-FCM-ZY46,F420
FR-FCM-ZY46,methanogenic archaea
FR-FCM-ZY46,16S rDNA sequencing
FR-FCM-ZY4F,T cell
FR-FCM-ZY4F,mass cytometry
FR-FCM-ZY4F,ccRCC
FR-FCM-ZY4F,Tumor associated macrophages
FR-FCM-ZY4N,B-cell
FR-FCM-ZY4N,High Throughput
FR-FCM-ZY4N,mouse
FR-FCM-ZY4N,Antibody Repertoire
FR-FCM-ZY4P,Innate Immune Response
FR-FCM-ZY4P,inflammation
FR-FCM-ZY4P,lacrimal gland
FR-FCM-ZY5L,IMMUNOPHENOTYPE
FR-FCM-ZY5L,Canine cardiosphere-derived cells
FR-FCM-ZY5L,mesenchymal stem cell
FR-FCM-ZY6Y,Yeast
FR-FCM-ZY6Y,galactose
FR-FCM-ZY6Y,dynamic gene expression
FR-FCM-ZY6Y,GFP reporter
FR-FCM-ZY6Y,GAL network
FR-FCM-ZY6Y,diauxic shift
FR-FCM-ZY66,flow cytometry
FR-FCM-ZY66,mass cytometry
FR-FCM-ZY66,CyTOF
FR-FCM-ZY66,Standardization
FR-FCM-ZY66,mouse
FR-FCM-ZY66,immune-monitoring
FR-FCM-ZY68,bromodomain inhibitor
FR-FCM-ZY68,mixed-lineage leukemia
FR-FCM-ZY68,replication
FR-FCM-ZY68,reproducibility
FR-FCM-ZY68,metascience
FR-FCM-ZY68,Reproducibility Project: Cancer Biology
FR-FCM-ZY69,mass cytometry
FR-FCM-ZY69,CyTOF
FR-FCM-ZY69,mouse
FR-FCM-ZY69,tumor
FR-FCM-ZY69,PD-1
FR-FCM-ZY69,TIL
FR-FCM-ZY69,CTLA-4
FR-FCM-ZY69,checkpoint blockade
FR-FCM-ZY6A,mass cytometry
FR-FCM-ZY6A,CyTOF
FR-FCM-ZY6A,melanoma
FR-FCM-ZY6A,PD-1
FR-FCM-ZY6A,CTLA-4
FR-FCM-ZY6A,checkpoint blockade
FR-FCM-ZY6A,murine tumor model
FR-FCM-ZY6A,B16
FR-FCM-ZY6C,T cell
FR-FCM-ZY6C,mass cytometry
FR-FCM-ZY6C,CyTOF
FR-FCM-ZY6C,melanoma
FR-FCM-ZY6C,PD-1
FR-FCM-ZY6C,TIL
FR-FCM-ZY6C,CTLA-4
FR-FCM-ZY6C,checkpoint blockade
FR-FCM-ZY6D,Human prostate
FR-FCM-ZY6D,Benign prostatic hyperplasia
FR-FCM-ZY6D,Epithelia
FR-FCM-ZY6D,Tissue phenotyping
FR-FCM-ZY6M,flow cytometry
FR-FCM-ZY6M,microbial communities
FR-FCM-ZY6M,microbiology
FR-FCM-ZY6N,Fluorescent proteins
FR-FCM-ZY6N,Compensation
FR-FCM-ZY6N,mice
FR-FCM-ZY6N,Genetic Reporters
FR-FCM-ZY6X,Fluorescent proteins
FR-FCM-ZY6X,Compensation
FR-FCM-ZY6X,mice
FR-FCM-ZY6X,Genetic Reporters
FR-FCM-ZY7Z,Cancer
FR-FCM-ZY7Z,Phenotyping
FR-FCM-ZY7Z,mass cytometry
FR-FCM-ZY7Z,head and neck squamous cell carcinoma (HNSCC)
FR-FCM-ZY77,mass cytometry
FR-FCM-ZY77,Systems Biology
FR-FCM-ZY77,ASCT
FR-FCM-ZY7C,microbial flow cytometry
FR-FCM-ZY7C,saliva
FR-FCM-ZY7C,mouth microbiome
FR-FCM-ZY7C,cell counting
FR-FCM-ZY7C,microbial diversity]
FR-FCM-ZY7E,Gene expression
FR-FCM-ZY7E,fitness optimum
FR-FCM-ZY7E,robustness.
FR-FCM-ZY7U,characterization
FR-FCM-ZY7U,Mesenchymal stem cells
FR-FCM-ZY7U,Placenta
FR-FCM-ZY8Y,cis-regulatory mutations
FR-FCM-ZY8Y,expression noise
FR-FCM-ZY8Y,promoter activity
FR-FCM-ZY8Y,fitness
FR-FCM-ZY87,Intracellular Cytokine Staining
FR-FCM-ZY87,dendritic cells
FR-FCM-ZY87,Dengue
FR-FCM-ZY87,DENV
FR-FCM-ZY8B,Gene expression
FR-FCM-ZY8B,Mutation
FR-FCM-ZY8B,gene-by-environment interactions
FR-FCM-ZY8B,distribution of mutational effects
FR-FCM-ZY8B,polymorphism
FR-FCM-ZY8B,genetic architecture
FR-FCM-ZY8B,cis-regulation
FR-FCM-ZY8D,Gene expression
FR-FCM-ZY8D,Mutation
FR-FCM-ZY8D,gene-by-environment interactions
FR-FCM-ZY8D,distribution of mutational effects
FR-FCM-ZY8D,polymorphism
FR-FCM-ZY8D,genetic architecture
FR-FCM-ZY8D,cis-regulation
FR-FCM-ZY8G,fingerprinting
FR-FCM-ZY8G,Lactobacillus
FR-FCM-ZY8G,SG
FR-FCM-ZY8G,SGPI
FR-FCM-ZY9B,alveolar macrophage
FR-FCM-ZY9B,CyTOF
FR-FCM-ZY9B,Lung
FR-FCM-ZY9B,macrophage
FR-FCM-ZY9B,Tumor associated macrophages
FR-FCM-ZY9B,Smoking
FR-FCM-ZY9B,NSCLC
FR-FCM-ZY9B,cerium
FR-FCM-ZY9W,bronchoalveolar lavage
FR-FCM-ZY9W,mass cytometry
FR-FCM-ZY9W,CD4+ T cells
FR-FCM-ZY9W,sarcoidosis
FR-FCM-ZY9W,Löfgren's syndrome
FR-FCM-ZY9M,mass cytometry
FR-FCM-ZY9M,CyTOF
FR-FCM-ZY9M,NSCLC
FR-FCM-ZY9M,adenocarcinoma
FR-FCM-ZY9M,human; IL-17A; Streptococcus pneumoniae; CD4 T cell; macrophage; Lung
FR-FCM-ZY9N,mass cytometry
FR-FCM-ZY9N,CyTOF
FR-FCM-ZY9N,NSCLC
FR-FCM-ZY9N,adenocarcinoma
FR-FCM-ZY9X,Intracellular Cytokine Staining
FR-FCM-ZY9X,mass cytometry
FR-FCM-ZY9X,CyTOF
FR-FCM-ZY9X,NSCLC
FR-FCM-ZY9T,Gene expression
FR-FCM-ZY9T,Plasticity
FR-FCM-ZY9T,TDH3
FR-FCM-ZYA4,flow cytometry
FR-FCM-ZYA4,NK cells
FR-FCM-ZYA4,Cytotoxicity
FR-FCM-ZYA4,IFNg
FR-FCM-ZYA4,MSCs
FR-FCM-ZYAE,NK cells
FR-FCM-ZYAE,NK receptors
FR-FCM-ZYAE,human mesenchymal stromal cells (hMSC)
FR-FCM-ZYAJ,healthy controls
FR-FCM-ZYAJ,human PBMCs
FR-FCM-ZYAJ,CyTOF
FR-FCM-ZYB7,mesenchymal stromal cells (MSC)
FR-FCM-ZYB7,adipose derived stromal cells (ASC)
FR-FCM-ZYB7,adrenergic receptors
FR-FCM-ZYB8,mammary epithelial cells
FR-FCM-ZYB8,CyTOF
FR-FCM-ZYB8,Cell Signaling
FR-FCM-ZYBB,mammary epithelial cells
FR-FCM-ZYBB,mass cytometry
FR-FCM-ZYBB,Cell Signaling
FR-FCM-ZYBC,mammary epithelial cells
FR-FCM-ZYBC,mass cytometry
FR-FCM-ZYBC,Cell Signaling
FR-FCM-ZYBD,mammary epithelial cells
FR-FCM-ZYBD,mass cytometry
FR-FCM-ZYBD,Cell Signaling
FR-FCM-ZYBG,Innate Immune Response
FR-FCM-ZYBG,vaccines
FR-FCM-ZYBG,macaques
FR-FCM-ZYBN,Bacteria
FR-FCM-ZYBN,IL-17A
FR-FCM-ZYBN,IFN-γ
FR-FCM-ZYBN,innate immunity
FR-FCM-ZYBN,γδ T cell
FR-FCM-ZYBN,Bcl11b
FR-FCM-ZYBN,DN2a
FR-FCM-ZYBN,Granzyme
FR-FCM-ZYBN,Host defense
FR-FCM-ZYBN,Listeria monocytogenes
FR-FCM-ZYBP,flow cytometry
FR-FCM-ZYBP,OMIP
FR-FCM-ZYBP,plasma cells
FR-FCM-ZYBS,PBMC
FR-FCM-ZYBS,technical variability
FR-FCM-ZYBT,T lymphocyte
FR-FCM-ZYBT,Latent TB
FR-FCM-ZYBU,PBMC
FR-FCM-ZYBU,T lymphocyte
FR-FCM-ZYC2,Immunophenotyping
FR-FCM-ZYC2,human PBMCs
FR-FCM-ZYC2,dendritic cells
FR-FCM-ZYC2,high-dimensional cytometry
FR-FCM-ZYC2,antigen-presenting cells
FR-FCM-ZYC2,myeloid cells
FR-FCM-ZYC2,human tissue
FR-FCM-ZYC4,flow cytometry; data analysis; statistical analysis; normalization
FR-FCM-ZYC4,Multi-dimensional
FR-FCM-ZYC4,antibiotic susceptibility test
FR-FCM-ZYCR,APOPTOSIS
FR-FCM-ZYCR,BH3-only proteins
FR-FCM-ZYCR,JNK
FR-FCM-ZYDY,Thymus
FR-FCM-ZYDY,thymic epithelial cells
FR-FCM-ZYDY,thymic stromal cells
FR-FCM-ZYD2,Thymus
FR-FCM-ZYD2,thymic epithelial cells
FR-FCM-ZYD2,thymic organ cultures
FR-FCM-ZYD5,monocytes
FR-FCM-ZYD5,ADCC
FR-FCM-ZYD5,Granzyme B
FR-FCM-ZYD5,natural killer (NK cells)
FR-FCM-ZYDC,B cells
FR-FCM-ZYDC,chemokine receptors
FR-FCM-ZYDC,NK cells
FR-FCM-ZYDC,T cells
FR-FCM-ZYDC,dendritic cells
FR-FCM-ZYDC,myeloid cells
FR-FCM-ZYDC,human blood immunophenotyping
FR-FCM-ZYDD,Immunophenotyping
FR-FCM-ZYDD,human PBMCs
FR-FCM-ZYDD,multi-parametric flow cytometry
FR-FCM-ZYDD,immunology
FR-FCM-ZYDD,multiparametric analysis
FR-FCM-ZYDW,bead-based separation
FR-FCM-ZYDW,mass cytometry
FR-FCM-ZYDW,CyTOF
FR-FCM-ZYDW,CyTOF; mass cytometry; flow cytometry; standardization
FR-FCM-ZYDW,viSNE
FR-FCM-ZYDW,SPADE
FR-FCM-ZYDW,PhenoGraph
FR-FCM-ZYDW,Citrus
FR-FCM-ZYDW,X-shift
FR-FCM-ZYDW,VorteX
FR-FCM-ZYDW,non-small cell lung cancer
FR-FCM-ZYDW,gHV68
FR-FCM-ZYDL,CD82
FR-FCM-ZYDL,PDGFRa
FR-FCM-ZYEB,flow cytometry
FR-FCM-ZYEB,PBMC
FR-FCM-ZYEB,signaling
FR-FCM-ZYEB,Barcoding
FR-FCM-ZYEB,Multiparameter
FR-FCM-ZYEB,Phosphorylation
FR-FCM-ZYEF,Sjögren’s syndrome
FR-FCM-ZYEF,extraglandular manifestations
FR-FCM-ZYEF,autoantibodies
FR-FCM-ZYEF,phosphoflow
FR-FCM-ZYEF,type I interferon
FR-FCM-ZYEV,JNK
FR-FCM-ZYEV,Breast Cancer
FR-FCM-ZYEV,Cell death
FR-FCM-ZYEV,Cell survival
FR-FCM-ZYFB,B cells
FR-FCM-ZYFB,chemokine receptors
FR-FCM-ZYFB,plasmablasts
FR-FCM-ZYFB,cytokine receptors
FR-FCM-ZYFB,surface immunoglobulin isotypes
FR-FCM-ZYFB,chronic viral diseases
FR-FCM-ZYFN,SHIME
FR-FCM-ZYFN,clindamycin
FR-FCM-ZYFN,AXOS
FR-FCM-ZYFN,wheat bran
FR-FCM-ZYFV,hematopoietic stem cells
FR-FCM-ZYFV,mass cytometry
FR-FCM-ZYFV,CyTOF
FR-FCM-ZYFV,HSC
FR-FCM-ZYFV,Progenitor Cells
FR-FCM-ZYFV,Human cord blood
FR-FCM-ZYFV,CD34+
FR-FCM-ZYFV,haematopoiesis
FR-FCM-ZYFV,CD49f cells
FR-FCM-ZYFV,haematopoietic stem cell
FR-FCM-ZYGA,flow cytometry
FR-FCM-ZYGA,dimension reduction
FR-FCM-ZYGA,Compensation
FR-FCM-ZYGA,high-dimensional cytometry
FR-FCM-ZYGA,automated data analysis
FR-FCM-ZYGA,automated phenotyping
FR-FCM-ZYGA,unsupervised clustering
FR-FCM-ZYGA,data preparation
FR-FCM-ZYGA,spectral data
FR-FCM-ZYGA,pseudo-spectral data
FR-FCM-ZYGA,data-input modes evaluation
FR-FCM-ZYGW,ergothioneine
FR-FCM-ZYGW,mycothiol
FR-FCM-ZYGW,gamma-glutamylcysteine
FR-FCM-ZYGW,mycobacterial membrane
FR-FCM-ZYGW,thiols secretion
FR-FCM-ZYGV,Bacteria
FR-FCM-ZYGV,water
FR-FCM-ZYHZ,monocytes
FR-FCM-ZYHZ,whole blood
FR-FCM-ZYHZ,activation
FR-FCM-ZYHZ,CyTOF
FR-FCM-ZYHZ,Phosphorylation
FR-FCM-ZYHZ,SmartTube
FR-FCM-ZYHZ,Sickle Cell disease
FR-FCM-ZYHY,Bacteria
FR-FCM-ZYHY,water
FR-FCM-ZYH2,Bacteria
FR-FCM-ZYH2,water
FR-FCM-ZYHB,Bacteria
FR-FCM-ZYHB,water
FR-FCM-ZYHL,flow cytometry
FR-FCM-ZYHL,dimension reduction
FR-FCM-ZYHL,Compensation
FR-FCM-ZYHL,high-dimensional cytometry
FR-FCM-ZYHL,automated data analysis
FR-FCM-ZYHL,automated phenotyping
FR-FCM-ZYHL,unsupervised clustering
FR-FCM-ZYHL,data preparation
FR-FCM-ZYHL,spectral data
FR-FCM-ZYHL,pseudo-spectral data
FR-FCM-ZYHL,data-input modes evaluation
FR-FCM-ZYWY,CD8
FR-FCM-ZYWY,mass cytometry
FR-FCM-ZYWY,CyTOF
FR-FCM-ZYWY,high-dimensional cytometry
FR-FCM-ZYWY,One-SENSE
FR-FCM-ZYWY,t-SNE
FR-FCM-ZYW7,melanoma
FR-FCM-ZYW7,tumor microenvironment
FR-FCM-ZYW7,CyTOF; mass cytometry;cancer
FR-FCM-ZYW8,mass cytometry
FR-FCM-ZYW8,CyTOF
FR-FCM-ZYW8,melanoma
FR-FCM-ZYW9,high content flow cytometry
FR-FCM-ZYW9,Immunophenotyping
FR-FCM-ZYW9,mass cytometry
FR-FCM-ZYW9,melanoma
FR-FCM-ZYWA,Immunophenotyping
FR-FCM-ZYWA,mass cytometry
FR-FCM-ZYWA,melanoma
FR-FCM-ZYWC,Immunophenotyping
FR-FCM-ZYWC,mass cytometry
FR-FCM-ZYWC,melanoma
FR-FCM-ZYWC,tumor
FR-FCM-ZYWM,Cancer
FR-FCM-ZYWM,mass cytometry
FR-FCM-ZYWM,CyTOF
FR-FCM-ZYWS,Gene expression
FR-FCM-ZYWS,Evolution
FR-FCM-ZYWS,Yeast
FR-FCM-ZYWT,Gene expression
FR-FCM-ZYWT,Evolution
FR-FCM-ZYWT,Yeast
FR-FCM-ZYWU,Gene expression
FR-FCM-ZYWU,Evolution
FR-FCM-ZYWU,Yeast
FR-FCM-ZYWU,cis-regulation
FR-FCM-ZYWV,Gene expression
FR-FCM-ZYWV,Evolution
FR-FCM-ZYWV,Yeast
FR-FCM-ZYWV,cis-regulation
FR-FCM-ZYJZ,Gene expression
FR-FCM-ZYJZ,Evolution
FR-FCM-ZYJZ,Yeast
FR-FCM-ZYJZ,cis-regulation
FR-FCM-ZYJY,Gene expression
FR-FCM-ZYJY,Evolution
FR-FCM-ZYJY,Yeast
FR-FCM-ZYJY,cis-regulation
FR-FCM-ZYJ2,Gene expression
FR-FCM-ZYJ2,Evolution
FR-FCM-ZYJ2,Yeast
FR-FCM-ZYJ2,cis-regulation
FR-FCM-ZYJN,fitness optimum
FR-FCM-ZYJN,expression noise
FR-FCM-ZYJN,cell proliferation
FR-FCM-ZYJX,expression noise
FR-FCM-ZYJX,Positional effect
FR-FCM-ZYJX,Expression level
FR-FCM-ZYKR,T-cells
FR-FCM-ZYKR,mitochondria
FR-FCM-ZYKR,Immunologic techniques
FR-FCM-ZYL6,gold nanoparticles
FR-FCM-ZYL6,dilution
FR-FCM-ZYL8,CyTOF
FR-FCM-ZYL8,high-dimensional cytometry
FR-FCM-ZYLB,single species
FR-FCM-ZYLB,phototrophic biofilm
FR-FCM-ZYLF,T cell
FR-FCM-ZYLF,CD8
FR-FCM-ZYLF,tSNE
FR-FCM-ZYLF,polychromatic flow cytometry
FR-FCM-ZYLF,single cell
FR-FCM-ZYLF,high-dimensional data
FR-FCM-ZYMC,flow cytometry
FR-FCM-ZYMC,CytoBackBone
FR-FCM-ZYMC,single cell level
FR-FCM-ZYMD,mass cytometry
FR-FCM-ZYMD,CytoBackBone
FR-FCM-ZYMD,single cell level
FR-FCM-ZYMF,HIV
FR-FCM-ZYMF,inflammatory markers
FR-FCM-ZYMF,mass cytometry
FR-FCM-ZYN7,Human preterm cord blood
FR-FCM-ZYN7,myeloid dendritic cells
FR-FCM-ZYN7,dendritic cells
FR-FCM-ZYN7,antigen-presenting cells
FR-FCM-ZYN7,intestine
FR-FCM-ZYN7,gut
FR-FCM-ZYND,Eosinophils
FR-FCM-ZYND,glucocorticoids
FR-FCM-ZYND,CXCR4
FR-FCM-ZYND,CCR1
FR-FCM-ZYND,CCR3
FR-FCM-ZYNE,APOPTOSIS
FR-FCM-ZYNE,Eosinophils
FR-FCM-ZYNE,glucocorticoids
FR-FCM-ZYNJ,Sperm
FR-FCM-ZYNJ,propidium iodide
FR-FCM-ZYNJ,SYBR Green I
FR-FCM-ZYNV,dendritic cells
FR-FCM-ZYNV,IBD
FR-FCM-ZYNV,anti-TNF-a
FR-FCM-ZYX4,T-cells
FR-FCM-ZYX4,mitochondria
FR-FCM-ZYX4,Immunologic techniques
FR-FCM-ZYX8,Embryonic stem cells
FR-FCM-ZYX8,cardiac differentiation
FR-FCM-ZYPM,mass cytometry
FR-FCM-ZYPM,CyTOF
FR-FCM-ZYPM,mouse
FR-FCM-ZYPM,tumor
FR-FCM-ZYPM,PD-1
FR-FCM-ZYPM,CTLA-4
FR-FCM-ZYPM,T3 tumor
FR-FCM-ZYPM,checkpoint therapy
FR-FCM-ZYPN,mass cytometry
FR-FCM-ZYPN,CyTOF
FR-FCM-ZYPN,tumor
FR-FCM-ZYPN,PD-1
FR-FCM-ZYPN,CTLA-4
FR-FCM-ZYPN,checkpoint therapy
FR-FCM-ZYPN,T3 MCA sarcoma
FR-FCM-ZYPN,time course
FR-FCM-ZYPX,mass cytometry
FR-FCM-ZYPX,tumor
FR-FCM-ZYPX,PD-1
FR-FCM-ZYPX,CTLA-4
FR-FCM-ZYPX,checkpoint therapy
FR-FCM-ZYPX,T3 MCA sarcoma
FR-FCM-ZYPX,anti IFNg
FR-FCM-ZYQ9,B cells
FR-FCM-ZYQ9,flow cytometry
FR-FCM-ZYQ9,NK cells
FR-FCM-ZYQ9,monocytes
FR-FCM-ZYQ9,healthy controls
FR-FCM-ZYQ9,T cells
FR-FCM-ZYQ9,dendritic cells
FR-FCM-ZYQ9,bone marrow
FR-FCM-ZYQ9,bone marrow mononuclear cells
FR-FCM-ZYQB,T cell
FR-FCM-ZYQB,CD4 T cells
FR-FCM-ZYQB,CD8 T cells
FR-FCM-ZYQB,bone marrow
FR-FCM-ZYQB,T regulatory cells
FR-FCM-ZYQB,bone marrow mononuclear cells
FR-FCM-ZYQB,healthy
FR-FCM-ZYQL,hematopoiesis
FR-FCM-ZYQL,cell cycle measurement
FR-FCM-ZYQL,mass cy
FR-FCM-ZYQL,IdU staining
FR-FCM-ZYQP,flow cytometry
FR-FCM-ZYQP,single cell suspension
FR-FCM-ZYQP,tissue digestion
FR-FCM-ZYQP,disaggregation
FR-FCM-ZYQT,automated gating
FR-FCM-ZYQT,Immunophenotyping
FR-FCM-ZYQT,multi-site study
FR-FCM-ZYQT,standardized flow cytometry
FR-FCM-ZYQT,Blood-based biomarkers
FR-FCM-ZYRD,CD4 T cells
FR-FCM-ZYRD,mass cytometry
FR-FCM-ZYRD,human fetal intestine
FR-FCM-ZYSA,CyTOF
FR-FCM-ZYSA,E. coli
FR-FCM-ZYSA,lectin
FR-FCM-ZYSA,metal-chelating polymer
FR-FCM-ZYSA,O-antigen transport
FR-FCM-ZYTZ,human PBMCs
FR-FCM-ZYTZ,mass cytometry
FR-FCM-ZYTZ,CyTOF
FR-FCM-ZYTZ,infectious disease
FR-FCM-ZYTZ,chikungunya
FR-FCM-ZYTY,Blood
FR-FCM-ZYTY,Progenitor Cells
FR-FCM-ZYTY,panel design
FR-FCM-ZYTY,bone marrow
FR-FCM-ZYTY,Hematopoietic cells
FR-FCM-ZYTY,HSCs
FR-FCM-ZYTR,flow cytometry
FR-FCM-ZYTR,human PBMCs
FR-FCM-ZYTR,cell surface markers
FR-FCM-ZYTR,Monocyte subpopulation
FR-FCM-ZYTR,Chagas disease
FR-FCM-ZYUF,spleen
FR-FCM-ZYUF,mass cytometry
FR-FCM-ZYUF,glioblastoma
FR-FCM-ZYUF,mouse
FR-FCM-ZYUF,bone marrow
FR-FCM-ZYUF,brain
